FJAN | PDEC | FJAN / PDEC | |
Gain YTD | 12.890 | 9.658 | 133% |
Net Assets | 754M | 746M | 101% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 0.00 | 0.00 | - |
Yield | 0.00 | 0.00 | - |
Fund Existence | 4 years | 5 years | - |
FJAN | PDEC | |
---|---|---|
RSI ODDS (%) | 2 days ago63% | 2 days ago49% |
Stochastic ODDS (%) | 2 days ago54% | 2 days ago48% |
Momentum ODDS (%) | 2 days ago89% | 7 days ago69% |
MACD ODDS (%) | 2 days ago82% | 2 days ago63% |
TrendWeek ODDS (%) | 2 days ago73% | 2 days ago66% |
TrendMonth ODDS (%) | 2 days ago70% | 2 days ago63% |
Advances ODDS (%) | 4 days ago71% | 9 days ago65% |
Declines ODDS (%) | 16 days ago61% | N/A |
BollingerBands ODDS (%) | 2 days ago63% | 2 days ago43% |
Aroon ODDS (%) | 2 days ago66% | 2 days ago61% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BMPEX | 26.03 | 0.25 | +0.97% |
Beck Mack + Oliver Partners | |||
MRFOX | 33.12 | 0.21 | +0.64% |
Marshfield Concentrated Opportunity | |||
LMTIX | 24.58 | 0.13 | +0.53% |
Franklin U.S. Large Cap Equity I | |||
RPMGX | 110.65 | 0.47 | +0.43% |
T. Rowe Price Mid-Cap Growth | |||
GEMAX | 23.03 | N/A | N/A |
Goldman Sachs Emerging Markets Eq A |